Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Current research efforts are three-pronged and directed at extending the duration of Levodopas efficacy, controlling these additional non-motor symptoms, and developing new strategies designed to offer neuroprotection and overall disease reversal benefits
Serious risks are rare but possible, including inflammation of the pancreas, gallbladder issues, or changes in mood
Heres how it performed since: So, while the longs still did continue to manage going up more than the shorts, the total return of the basket was much less than the S&P500 (which I benchmark long/short to, even though prevailing wisdom is to benchmark it to T-Bills)
The company does not publicly name a founder, CEO, or founding date there is no executive LinkedIn, no Crunchbase entry, and no press releases of substance
The Philippine Food and Drug Administration (FDA) is conducting a consultation on plans to offer enhanced regulatory support and priority processing lanes for locally manufactured pharmaceutical products
US$ 27.21
US$ 25.85
US$ 25.65
US$ 29.78
US$ 29.93
